Indeed, we have assayed serum and urine ALCAM in the same cohort of subjects (data not shown), where we find that uALCAM was able to significantly discriminate active LN from other patients with SLE (AUC values > 92%), whereas sALCAM failed to do so. The gene discussed is ALCAM; the disease is systemic lupus erythematosus.